Real Safety and Efficacy of a 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation - RESET Trial


The goal of the trial was to evaluate treatment with a zotarolimus-eluting stent (Endeavor) and 3 months of dual antiplatelet therapy compared with other drug-eluting stent types and 12 months of dual antiplatelet therapy.